NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
1.150
-0.030 (-2.54%)
Oct 29, 2025, 4:00 PM EDT - Market closed

NewGenIvf Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
4.775.435.145.944.12
Revenue Growth (YoY)
-16.16%5.79%-13.59%44.34%-
Cost of Revenue
3.263.613.454.413.09
Gross Profit
1.51.831.681.541.02
Selling, General & Admin
5.612.991.641.140.83
Operating Expenses
5.612.991.641.140.83
Operating Income
-4.11-1.160.040.40.2
Interest Expense
-0.79-0.78-0.05-0.08-0.09
Interest & Investment Income
-0.01000
Other Non Operating Income (Expenses)
5.030.970.110.020.05
Pretax Income
0.13-0.960.110.340.16
Income Tax Expense
-0.49-0.49-0.210.29
Earnings From Continuing Operations
0.61-0.470.110.14-0.14
Minority Interest in Earnings
-0.01-0.050.020.320.14
Net Income
0.6-0.520.130.46-0
Net Income to Common
0.6-0.520.130.46-0
Net Income Growth
1336.63%--71.61%--
Free Cash Flow
-13.48-8.32-1.841.621.42
Gross Margin
31.51%33.62%32.74%25.87%24.88%
Operating Margin
-86.30%-21.36%0.82%6.71%4.83%
Profit Margin
12.52%-9.66%2.54%7.72%-0.01%
Free Cash Flow Margin
-282.73%-153.08%-35.75%27.19%34.39%
EBITDA
-4.1-1.140.070.50.37
EBITDA Margin
-85.95%-21.00%1.43%8.40%8.88%
D&A For EBITDA
0.020.020.030.10.17
EBIT
-4.11-1.160.040.40.2
EBIT Margin
-86.30%-21.36%0.82%6.71%4.83%
Effective Tax Rate
---60.51%188.70%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q